David J. Wambeke - Net Worth and Insider Trading
David J. Wambeke Net Worth
The estimated net worth of David J. Wambeke is at least $1 Million dollars as of 2024-05-23. David J. Wambeke is the Chief Business Officer of DiaMedica Therapeutics Inc and owns about 527,114 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $1 Million. Details can be seen in David J. Wambeke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David J. Wambeke has not made any transactions after 2023-11-16 and currently still holds the listed stock(s).
Transaction Summary of David J. Wambeke
David J. Wambeke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J. Wambeke owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of David J. Wambeke’s form 4 insider trades.
Insider Ownership Summary of David J. Wambeke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | Chief Business Officer |
David J. Wambeke Latest Holdings Summary
David J. Wambeke currently owns a total of 1 stock. David J. Wambeke owns 527,114 shares of DiaMedica Therapeutics Inc (DMAC) as of November 16, 2023, with a value of $1 Million.
Latest Holdings of David J. Wambeke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-11-16 | 527,114 | 2.83 | 1,489,097 |
Holding Weightings of David J. Wambeke
David J. Wambeke Form 4 Trading Tracker
According to the SEC Form 4 filings, David J. Wambeke has made a total of 3 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 20,000 shares on November 16, 2023, which cost David J. Wambeke around $49,200.
Insider Trading History of David J. Wambeke
- 1
David J. Wambeke Trading Performance
GuruFocus tracks the stock performance after each of David J. Wambeke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J. Wambeke is 41.55%. GuruFocus also compares David J. Wambeke's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J. Wambeke within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David J. Wambeke's insider trading performs compared to the benchmark.
Performance of David J. Wambeke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.6 | | | | | |
| Relative Return to S&P 500(%) | -1.63 | | | | | |
David J. Wambeke Ownership Network
David J. Wambeke Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
David J. Wambeke is the Chief Business Officer of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include CFO and Secretary Scott Kellen , director & President and CEO Dietrich John Pauls , and 10 percent owner Ab Tomenterprise .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, David J. Wambeke made 3 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 527,114. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 215,000 shares made by Randall Michael Giuffre , a net purchase of 1,470,588 shares made by Koch Thomas Von , and a net purchase of 73,363 shares made by Richard D. Pilnik .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
David J. Wambeke Mailing Address
Above is the net worth, insider trading, and ownership report for David J. Wambeke. You might contact David J. Wambeke via mailing address: 301 Carlson Parkway, Suite 210, Minneapolis Mn 55305.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
